Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique (HOT)

October 21, 2015 updated by: Centre Hospitalier Universitaire de Nīmes

Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique : a Prospective, Randomized, Multicenter Study Evaluating the Length of Hospital Stay

The main objective of the study is the comparison of the effective duration of hospitalization following laparoscopic hysterectomy via a single-port peri-umbilical technique versus an conventional multi-port technique.

Study Overview

Detailed Description

The secondary objectives are to compare the following between the two arms of the study:

  1. the difference between the real discharge date and the theoretical discharge date
  2. measures related to intraoperative bleeding
  3. operating time
  4. postoperative pain
  5. quality of life
  6. abdominal wall complication rates
  7. rates of further surgery and rehospitalization
  8. use of material resources in the operating room
  9. average costs of hospital stay
  10. Costs of rehospitalization at 1 year
  11. Indirect costs

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Marseille, France, 13385
        • APHM - Hôpital de la Conception
      • Nîmes Cedex 9, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau
      • Saint-Priest en Jarez, France, 42270
        • CHU de Saint Etienne - Hopital Nord

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • The patient must have given her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 12 months of follow-up
  • The patient is declared fit by the anesthetist for an intervention by laparoscopy

Exclusion Criteria:

  • The patient is not available for 12 months of follow-up
  • The patient is participating in another study or is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient is not insured or beneficiary of a health insurance plan
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient cannot read French
  • Patient with a history of pelvic radiotherapy
  • Patient with a history of pelvic surgery or serious risk of major adhesions
  • The patient is pregnant
  • Contraindications for anesthesia for either surgical technique
  • Promontofixation or lymphadenectomy
  • No associated procedure other than morcellation or vaginal suture for extracting the hysterectomy specimen, unilateral or bilateral oophorectomy
  • The patient has a known or suspected allergy to polyurethane
  • Extended hysterectomy for neoplastic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Peri-umbilical single-port

Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique.

Intervention: Single-port, peri-umbilical hysterectomy

Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique.
Active Comparator: Multi-port

Patients in this arm have a hysterectomy via a conventional multi-port laparoscopic surgical technique.

Intervention: Multi-port hysterectomy

Patients in this arm have a hysterectomy via a conventional multi-port laparoscopic surgical technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Length of hospital stay in hours
Time Frame: Maximum 1 month (usually 3 to 5 days)
Maximum 1 month (usually 3 to 5 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in hours between real discharge time and theoretical discharge time
Time Frame: 4 weeks

Criteria for theoretical hospital discharge:

  • Visual analog scale for pain < 2 under stage 1 antalgics
  • No nausea, no vomiting
  • Resumption of transit, liquid and solid food
  • Capable of getting up, moving and going to the bathroom alone
  • Apyrexia
4 weeks
Bleeding/fluid loss: Difference between lavage fluids and aspiration fluids
Time Frame: Day 0 (during surgery)
Day 0 (during surgery)
Change in hemoglobin measure
Time Frame: Day 3 versus baseline
Day 3 versus baseline
Change in hematocrit measure
Time Frame: Day 3 versus baseline
Day 3 versus baseline
Surgical time, from first incision to closing
Time Frame: Day 0 (during surgery)
Day 0 (during surgery)
Visual analog scale for pain
Time Frame: 2 hours after end of surgery (Day 0)
2 hours after end of surgery (Day 0)
Visual analog scale for pain
Time Frame: 3 times per day during hospitalisation (expected maximum of 3 to 5 days)
3 times per day during hospitalisation (expected maximum of 3 to 5 days)
Questionnaire SF 36
Time Frame: baseline
Quality of Life
baseline
Questionnaire SF 36
Time Frame: 4 weeks
Quality of Life
4 weeks
Complication rate
Time Frame: Day 1
Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation
Day 1
Complication rate
Time Frame: 4 weeks
Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation
4 weeks
Complication rate
Time Frame: 12 months
Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation
12 months
Re-intervention/hospitalisation rate
Time Frame: 12 months
12 months
Surgical conversion rate
Time Frame: Day 0 (during surgery)
Day 0 (during surgery)
Trocar site infection rate
Time Frame: 4 weeks
4 weeks
Presence/absence of complications according to Clavien scale
Time Frame: Day 1
Day 1
Presence/absence of complications according to Clavien scale
Time Frame: 12 months
12 months
Inventory of reusable material in the operating room and related costs.
Time Frame: Day 0 (after surgery)
Day 0 (after surgery)
Estimatin of indirect costs
Time Frame: 4 weeks
4 weeks
Estimation of direct costs
Time Frame: 12 months
12 months
Questionnaire SF 36
Time Frame: 12 months
Quality of Life
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

April 10, 2013

First Submitted That Met QC Criteria

April 11, 2013

First Posted (Estimate)

April 12, 2013

Study Record Updates

Last Update Posted (Estimate)

October 22, 2015

Last Update Submitted That Met QC Criteria

October 21, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • LOCAL/2012/VL-03
  • 2012-A01054-36 (Other Identifier: RCB number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hysterectomy

Clinical Trials on Single-port, peri-umbilical hysterectomy

Subscribe